v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Operating activities: Ìý Ìý Ìý
Net loss $ (20,640) $ (54,900) $ (69,048)
Adjustments to reconcile net loss to net cash used in operating activities: Ìý Ìý Ìý
Depreciation and amortization Ìý 3,737 4,302
Reduction in the carrying amount of right-of-use assets Ìý 2,364 3,647
Stock-based compensation 2,708 10,561 7,808
Asset impairment and other charges 0 165 9,984
Impairment of investment in non-marketable equity securities 3,900 3,910 3,875
Equity securities earned from research and development activities Ìý 0 (187)
Non-cash interest expense Ìý 611 0
Amortization of discount on short-term investments Ìý (1,009) 0
Other non-cash items Ìý 11 (3)
Changes in operating assets and liabilities: Ìý Ìý Ìý
Financial assets Ìý 2,818 21,580
Inventories Ìý 582 (276)
Prepaid expenses and other assets Ìý 1,417 (252)
Accounts payable Ìý (1,339) (105)
Accrued compensation and other accrued liabilities Ìý 1,334 (7,269)
Other long-term liabilities Ìý (3,064) (4,384)
Deferred revenue Ìý (140) (11,273)
Net cash used in operating activities Ìý (32,942) (41,601)
Investing activities: Ìý Ìý Ìý
Purchase of property and equipment Ìý (2,531) (4,798)
Proceeds from sale of property and equipment Ìý 84 27
Purchases of short-term investments Ìý (72,643) 0
Proceeds from maturity of short-term investments Ìý 19,000 0
Proceeds from sale of short-term investments Ìý 1,973 0
Investment in non-marketable securities Ìý 0 (1,191)
Net cash used in investing activities Ìý (54,117) (5,962)
Financing activities: Ìý Ìý Ìý
Proceeds from exercises of stock options Ìý 281 422
Proceeds from issuance of stock under employee stock purchase plan Ìý 525 0
Proceeds from issuance of common stock in connection with equity sales agreements Ìý 31,320 8,652
Costs incurred in connection with equity sales agreements Ìý (1,615) (503)
Proceeds from long-term debt Ìý 29,521 0
Payment of debt issuance costs Ìý (642) 0
Taxes paid related to net share settlement of equity awards Ìý 0 (404)
Net cash provided by financing activities Ìý 59,390 8,167
Net decrease in cash, cash equivalents and restricted cash Ìý (27,669) (39,396)
Cash, cash equivalents and restricted cash at the beginning of the period Ìý 66,697 116,026
Cash, cash equivalents and restricted cash at the end of the period 39,028 39,028 76,630
Supplemental disclosure of cash flow information: Ìý Ìý Ìý
Interest paid Ìý 1,633 28
Income taxes paid Ìý 17 193
Supplemental non-cash investing and financing activities: Ìý Ìý Ìý
Capital expenditures incurred but not yet paid Ìý 249 159
Cash reconciliation: Ìý Ìý Ìý
Cash and cash equivalents 37,452 37,452 74,577
Restricted cash, current and non-current 1,576 1,576 2,053
Total cash, cash equivalents and restricted cash 39,028 39,028 $ 76,630
Short-term investments 52,803 52,803 Ìý
Cash, cash equivalents, and short-term investments $ 90,255 $ 90,255 Ìý

Source